Novo Nordisk A/S (NONOF)
OTCMKTS · Delayed Price · Currency is USD
38.74
-0.14 (-0.36%)
Mar 10, 2026, 4:00 PM EST

Novo Nordisk Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
170,98535,24759,59072,38747,87640,141
Market Cap Growth
-53.80%-40.85%-17.68%51.20%19.27%57.64%
Enterprise Value
187,19450,66071,64371,72148,24641,638
PE Ratio
10.6214.0627.2437.5338.4735.31
Forward PE
11.76-----
PS Ratio
3.520.741.322.011.741.84
PB Ratio
5.601.172.684.383.703.66
P/TBV Ratio
0.891.172.684.363.683.65
P/FCF Ratio
18.453.855.205.614.625.32
P/OCF Ratio
9.131.913.184.283.914.70
EV/Sales Ratio
3.891.061.591.991.761.91
EV/EBITDA Ratio
7.752.183.134.133.784.15
EV/EBIT Ratio
8.542.563.604.514.164.58
EV/FCF Ratio
20.195.546.265.564.665.51
Debt / Equity Ratio
0.690.690.770.270.340.41
Debt / EBITDA Ratio
0.890.890.750.250.350.45
Debt / FCF Ratio
2.262.261.500.340.430.59
Net Debt / Equity Ratio
0.510.510.54-0.040.030.14
Net Debt / EBITDA Ratio
0.660.660.53-0.040.030.15
Net Debt / FCF Ratio
1.691.691.05-0.050.040.20
Asset Turnover
0.610.610.740.840.810.83
Inventory Turnover
1.301.301.231.271.291.24
Quick Ratio
0.570.570.570.640.690.67
Current Ratio
0.800.800.740.820.890.86
Return on Equity (ROE)
60.70%60.70%80.78%88.07%72.00%71.24%
Return on Assets (ROA)
19.86%19.86%26.12%29.51%27.60%27.93%
Return on Invested Capital (ROIC)
24.55%24.55%34.33%40.69%37.34%37.38%
Return on Capital Employed (ROCE)
44.36%44.36%65.30%77.37%69.49%69.14%
Earnings Yield
9.42%7.11%3.67%2.66%2.60%2.83%
FCF Yield
5.42%25.95%19.22%17.81%21.63%18.81%
Dividend Yield
4.29%3.59%1.61%1.01%1.19%1.28%
Payout Ratio
50.53%50.53%43.71%37.96%45.57%45.06%
Buyback Yield / Dilution
0.10%0.61%5.25%6.41%7.81%7.52%
Total Shareholder Return
4.38%4.20%6.86%7.43%8.99%8.80%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.